Acacia Research Corporation

Equities

ACTG

US0038813079

Business Support Services

Market Closed - Nasdaq 04:00:00 2024-04-17 pm EDT 5-day change 1st Jan Change
4.82 USD -2.23% Intraday chart for Acacia Research Corporation -3.60% +22.96%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Tranche Update on Acacia Research Corporation's Equity Buyback Plan announced on November 13, 2023. CI
Acacia Research Q4 Swings to Profit, Revenue Increases MT
Acacia Research Seeks Acquisitions CI
Transcript : Acacia Research Corporation, Q4 2023 Earnings Call, Mar 14, 2024
Earnings Flash (ACTG) ACACIA RESEARCH CORPORATION Posts Q4 Revenue $92.3M MT
Acacia Research Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Acacia Research Corporation Announces Board Changes CI
Acacia Research Appoints Martin McNulty Jr. as Permanent CEO MT
Acacia Research Corporation Appoints Martin D. Mcnulty as Director CI
Acacia Research Corporation Appoints Martin D. Mcnulty, Jr. as Permanent Chief Executive Officer CI
Katoro Gold launches fundraising, eyes board shake-up AN
Arix Bioscience shares suspended ahead of RTW takeover AN
RTW Biotech Buys Minority Stake in Arix Bioscience to Support Planned Takeover MT
Rtw Biotech Opportunities Operating Ltd completed the acquisition of a 26.6% stake in Arix Bioscience plc from Acacia Research Corporation for £47.2 million. CI
Acacia Research Reports Q3 Loss, Lower Revenue; Buys Majority Stake in Benchmark Energy II MT
Transcript : Acacia Research Corporation, Q3 2023 Earnings Call, Nov 13, 2023
Acacia Research Corporation announces an Equity Buyback for 5,800,000 shares, for $20 million. CI
Acacia Research Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Acacia Research Corporation acquired 50.4% stake in Benchmark Energy II, LLC from McArron Partners, L.P. for $10 million. CI
Acacia Research Corporation authorizes a Buyback Plan. CI
RTW Biotech agrees "immediately accretive" Arix Bioscience takeover AN
Rtw Biotech Opportunities Operating Ltd enter into an agreement to acquire 26.6% stake in Arix Bioscience plc from Acacia Research Corporation for £47.2 million. CI
Acacia Research Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Acacia Research Seeks Acquisitions CI
Transcript : Acacia Research Corporation, Q2 2023 Earnings Call, Aug 03, 2023
Chart Acacia Research Corporation
More charts
Acacia Research Corporation is focused on acquiring and managing companies across industries, including industrial, energy, technology, and healthcare verticals. Its Intellectual Property Operations segment invests in intellectual property (IP) and related absolute return assets and engages in the licensing and enforcement of patented technologies. Through its Patent Licensing, Enforcement and Technologies Business, it is a principal in the licensing and enforcement of patent portfolios, with its operating subsidiaries obtaining the rights in the patent portfolio or purchasing the patent portfolio outright. Its Industrial Operations segment is engaged in the design and manufacture of printers and consumable products for various industrial printing applications. Its Energy Operations segment includes its wells and engages in the acquisition, exploration, development, and production of oil and natural gas resources located in Roberts and Hemphill Counties in Texas.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.82 USD
Average target price
7 USD
Spread / Average Target
+45.23%
Consensus
  1. Stock Market
  2. Equities
  3. ACTG Stock
  4. News Acacia Research Corporation
  5. Acacia Research Names Martin McNulty Jr. as Chief Operating Officer